FDA Publishes SPL Guide for MoCRA Facility Registration and Product Listings
Client Alert | 1 min read | 11.01.23
On October 13, 2023 he FDA announced that two of the requirements set forth in the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)— facility registration and product listing—will be included as part of the Structured Product Labeling (SPL) framework. SPL is a document formatting standard adopted by FDA for exchanging product-related information.
The FDA previously developed Cosmetics Direct, a draft electronic portal for submissions under MoCRA. Companies who will use Cosmetics Direct may submit facility registration information and/or product listings by importing an SPL document, which contains user friendly data entry forms, performs initial validation, creates and saves the SPL submission, and submits the SPL document to FDA for internal processing.
In order to assist those who will be using and uploading SPL documents, the FDA also published a SPL Implementation Guide with technical conformance criteria for SPL documents. According to this Guide, importing an existing SPL document will be useful for bulk submissions, and users will be able to copy a successfully uploaded SPL document as a starting point for their own submission.
Contacts
Counsel
She/Her/Hers
Insights
Client Alert | 8 min read | 01.13.25
In a move that underscores the evolving landscape of global data governance, China announced a new initiative aimed at fostering cross-border data flows. On November 17, Chinese President Xi announced the launch of a “Global Cross-Border Data Flow Cooperation Initiative” while attending the Asia Pacific Economic Cooperation (APEC) leaders meeting in Lima, Peru. The following day, the Cyberspace Administration of China released further details about the initiative, which frames China as a proponent of non-discriminatory and cooperative data policies. However, closer analysis reveals a complex interplay of geopolitical, economic, and regulatory factors behind this initiative.
Client Alert | 2 min read | 01.13.25
Client Alert | 1 min read | 01.10.25
FAR Council Withdraws Proposed Mandatory Climate Disclosures for Federal Contractor Rule
Client Alert | 7 min read | 01.10.25
New Draft Guidance From FDA Explains When an Accelerated Approval Trial Is “Underway”
